Business Context and Reporting Period
This Form 8-K was filed by Gladstone Investment Corporation on December 28, 2006, reporting a significant investment event that occurred on the same date.
Key Financial Metrics and Transaction Details
The filing details a specific investment transaction rather than periodic financial results. Key metrics include:
- Total Investment: Approximately $22.9 million.
- Target Company: Acme Cryogenics, Inc. and its subsidiaries.
- Investment Structure:
- Preferred and common stock: Approximately $8.4 million.
- Subordinated notes (mezzanine debt): Approximately $14.5 million.
- Financing Source: Proceeds from borrowing under a revolving credit facility with Deutsche Bank A.G.
Material Changes
The filing reports a material change in the company's asset portfolio through the acquisition of equity and debt securities in Acme Cryogenics, Inc. No comparative financial data or prior period changes are provided in this specific report.
Outlook, Risks, and Management Commentary
The filing does not provide forward-looking guidance, management commentary on future performance, or specific risk factors beyond the nature of the investment. The target company, Acme Cryogenics, is described as a manufacturer of cryogenic manifolds, vacuum insulated pipes, and repair services for storage tanks and tank trailers used in transporting industrial gases.
Investor Verification Checklist
- Verify the terms and interest rates of the $14.5 million subordinated notes issued by Acme Cryogenics.
- Confirm the impact of the new debt on Gladstone Investment Corporation's leverage ratios and available capacity under its revolving credit facility with Deutsche Bank A.G.
- Review the valuation methodology used for the $8.4 million equity purchase in Acme Cryogenics.
- Assess the creditworthiness and operational stability of Acme Cryogenics, Inc.